Immuno-infrared sensor technology was employed to measure TDP-43 misfolding, and these measurements discriminated individuals with ALS from individuals with Parkinson’s disease with a sensitivity of 89% and specificity of 77%, and from patients with other neurological diseases with a sensitivity of 89% and specificity of 83%. Here, TARDBP is linked to nervous system disorder.